OSR Health, Inc.

OSRH Healthcare Biotechnology

OSR Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 million, down 17.7% from fiscal 2024. In the quarter to June 2026, revenue fell 72.2%, EPS fell 200.0%, free cash flow fell 398.8% and total debt rose 28.2%, each against the same quarter a year earlier.

0.22 0.02 +10.00%
Market cap
$4.1M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
−0.59
Beneish M
−4.91
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
(14.98%) (14.32%) (20.03%) (22.63%)

+8 more TTM periods

ROA
(11.24%) (10.73%) (15.62%) (14.68%)
ROIC
(8.19%) (9.12%) (8.84%) (6.22%)
Return on Tangible Assets
155.41% 125.48% 190.83% 123.85%
Average Days of Receivables
49.26 44.39 49.25 56.65
Free Cash Flow per Share
(0.22) (0.17) (0.24) (0.16)
Free Cash Flow
(7.20) (5.27) (4.76) (3.44)
Other line items

Show all line items

Columns are period end dates